• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Efficacy and tolerance assessment of mitrazapine in the treatment of depression in the elderly--preliminary report].

作者信息

Florkowski Antoni, Gruszczyński Wojciech, Zboralski Krzysztof

机构信息

Katedra i Klinika Psychiatrii Wojskowej Akademii Medycznej w Łodzi.

出版信息

Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):143-6.

PMID:12647433
Abstract

UNLABELLED

Depressive disorders are often met in the elderly, its course is usually protracted and outcome sometimes fatal. The purpose of this study is evaluation of efficacy and tolerance of mirtazapine in this group of patients. 24 patients (mean age 73.8) with major depressive episode (> 20 in 17-tem HAMD; also CGI scale was used for evaluation) without psychotic features were treated with mirtazapine (30-45 mg) for 6 months.

RESULTS

Improvement (especially such symptoms as better mood and sleep, less anxiety) could be seen in 75% of patients.

摘要

相似文献

1
[Efficacy and tolerance assessment of mitrazapine in the treatment of depression in the elderly--preliminary report].
Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):143-6.
2
[Assessment of efficacy and tolerability of mirtazapine treatment of patients with depression].[米氮平治疗抑郁症患者的疗效和耐受性评估]
Psychiatr Pol. 2002 Nov-Dec;36(6 Suppl):115-23.
3
Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial.米氮平治疗伴焦虑症状的重性抑郁障碍的疗效和耐受性:8 周开放标签随机帕罗西汀对照试验。
Int J Clin Pract. 2011 Mar;65(3):323-9. doi: 10.1111/j.1742-1241.2010.02624.x.
4
Mirtazapine orally disintegrating tablet versus sertraline: a prospective onset of action study.米氮平口腔崩解片与舍曲林:一项前瞻性起效研究
J Clin Psychopharmacol. 2003 Aug;23(4):358-64. doi: 10.1097/01.jcp.0000085408.08426.05.
5
Venlafaxine plus mirtazapine as first-line treatment for melancholia: preliminary results.文拉法辛联合米氮平作为忧郁症的一线治疗:初步结果
J Psychopharmacol. 2010 Dec;24(12):1837. doi: 10.1177/0269881110376696.
6
Efficacy, tolerability, and preference of mirtazapine orally disintegrating tablets in depressed patients: a 17-week naturalistic study in Lithuania.米氮平口腔崩解片治疗抑郁症患者的疗效、耐受性和偏好:立陶宛的一项为期 17 周的自然研究。
Medicina (Kaunas). 2009;45(10):778-84.
7
Repeated episodes of neutropenia triggered by mirtazapine.
Psychosomatics. 2009 May-Jun;50(3):299-300. doi: 10.1176/appi.psy.50.3.299.
8
Antidepressants and unresponsive episodes in the elderly.老年人中的抗抑郁药与无反应发作
BMJ Case Rep. 2012 Jul 17;2012:bcr0320126033. doi: 10.1136/bcr-03-2012-6033.
9
Mirtazapine-associated hyponatremia presenting as delirium.米氮平相关低钠血症表现为谵妄。
Indian J Pharmacol. 2014 Jul-Aug;46(4):448-9. doi: 10.4103/0253-7613.135964.
10
A double-blind multicentre comparison of mirtazapine and amitriptyline in elderly depressed patients.
Acta Psychiatr Scand. 1996 Mar;93(3):184-90. doi: 10.1111/j.1600-0447.1996.tb10629.x.